• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关成纤维细胞促进YAP液-液相分离,以促进肝癌中的癌细胞干性。

The cancer-associated fibroblast facilitates YAP liquid-liquid phase separation to promote cancer cell stemness in HCC.

作者信息

Chen Wei, Li Yanling, Zhou Qiaodan, Peng Wang, Cao Mengdie, Zhao Yuchong, Yang Zihan, Xiong Si, Huang Hai, Liu Luyao, Bai Shuya, Cheng Bin

机构信息

Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Road, No.1095, Wuhan, 430030, China.

School of Life Sciences, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, 999077, China.

出版信息

Cell Commun Signal. 2025 May 24;23(1):238. doi: 10.1186/s12964-025-02256-2.

DOI:10.1186/s12964-025-02256-2
PMID:40413530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12103779/
Abstract

Cancer stem cells (CSCs) are strongly associated with the refractory characteristics of Hepatocellular carcinoma (HCC). However, the complex interaction between CSCs and the tumor microenvironment remains incompletely understood. In this study, we identified a novel long non-coding RNA (lncRNA) NEAT1 in cancer-associated fibroblast (CAFs)-derived extracellular vesicles (EVs) that play a critical role in the induction of CSCs and HCC tumorigenesis. NEAT1 was significantly overexpressed in human HCC tissues. Furthermore, high expression of lncRNA NEAT1 in EVs was found to be associated with poor prognosis. Knockdown of NEAT1 in CAFs inhibited invasion, migration, and tumor growth. Mechanistically, NEAT1 promoted cancer cell stemness, including 3D spheroid formation, by facilitating the liquid-liquid phase separation (LLPS) of the transcription factor YAP. Specifically, NEAT1 is directly bound to the intrinsic disordered region in the YAP protein, promoting the formation of LLPS biomolecular condensates. Additionally, a positive correlation between NEAT1 and Nanog was observed in clinical HCC tissues. In conclusion, our findings reveal that NEAT1 promotes HCC carcinogenesis and CSC induction by facilitating the LLPS of the YAP protein.

摘要

癌症干细胞(CSCs)与肝细胞癌(HCC)的难治性特征密切相关。然而,CSCs与肿瘤微环境之间的复杂相互作用仍未完全了解。在本研究中,我们在癌症相关成纤维细胞(CAFs)衍生的细胞外囊泡(EVs)中鉴定出一种新型长链非编码RNA(lncRNA)NEAT1,其在CSCs诱导和HCC肿瘤发生中起关键作用。NEAT1在人类HCC组织中显著过表达。此外,发现EVs中lncRNA NEAT1的高表达与预后不良相关。敲低CAFs中的NEAT1可抑制侵袭、迁移和肿瘤生长。机制上,NEAT1通过促进转录因子YAP的液-液相分离(LLPS)来促进癌细胞干性,包括3D球体形成。具体而言,NEAT1直接与YAP蛋白的内在无序区域结合,促进LLPS生物分子凝聚物的形成。此外,在临床HCC组织中观察到NEAT1与Nanog之间呈正相关。总之,我们的研究结果表明,NEAT1通过促进YAP蛋白的LLPS来促进HCC致癌作用和CSC诱导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/0f69b8c7c703/12964_2025_2256_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/3f955612dbda/12964_2025_2256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/fe5cbd30225f/12964_2025_2256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/609d09ca3158/12964_2025_2256_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/852310e55420/12964_2025_2256_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/f5952ab2e83e/12964_2025_2256_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/b408cae50bfb/12964_2025_2256_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/0f69b8c7c703/12964_2025_2256_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/3f955612dbda/12964_2025_2256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/fe5cbd30225f/12964_2025_2256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/609d09ca3158/12964_2025_2256_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/852310e55420/12964_2025_2256_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/f5952ab2e83e/12964_2025_2256_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/b408cae50bfb/12964_2025_2256_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/224a/12103779/0f69b8c7c703/12964_2025_2256_Fig7_HTML.jpg

相似文献

1
The cancer-associated fibroblast facilitates YAP liquid-liquid phase separation to promote cancer cell stemness in HCC.癌症相关成纤维细胞促进YAP液-液相分离,以促进肝癌中的癌细胞干性。
Cell Commun Signal. 2025 May 24;23(1):238. doi: 10.1186/s12964-025-02256-2.
2
lncRNA NEAT1 regulates the proliferation and migration of hepatocellular carcinoma cells by acting as a miR‑320a molecular sponge and targeting L antigen family member 3.长链非编码 RNA NEAT1 通过作为 miR-320a 的分子海绵并靶向 L 抗原家族成员 3 调节肝癌细胞的增殖和迁移。
Int J Oncol. 2020 Oct;57(4):1001-1012. doi: 10.3892/ijo.2020.5108. Epub 2020 Aug 10.
3
Phase separation of EEF1E1 promotes tumor stemness via PTEN/AKT-mediated DNA repair in hepatocellular carcinoma.EEF1E1的相分离通过PTEN/AKT介导的DNA修复促进肝癌中的肿瘤干性。
Cancer Lett. 2025 Mar 31;613:217508. doi: 10.1016/j.canlet.2025.217508. Epub 2025 Jan 28.
4
Cancer-associated fibroblasts-secreted exosomal miR-92a-3p promotes tumor growth and stemness in hepatocellular carcinoma through activation of Wnt/β-catenin signaling pathway by suppressing AXIN1.癌相关成纤维细胞分泌的外泌体 miR-92a-3p 通过抑制 AXIN1 激活 Wnt/β-连环蛋白信号通路促进肝癌的肿瘤生长和干细胞特性。
J Cell Physiol. 2024 Sep;239(9):e31344. doi: 10.1002/jcp.31344. Epub 2024 Jul 1.
5
Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.长链非编码RNA NEAT1通过调控miR-129-5p-VCP-IκB促进肝癌细胞增殖。
Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1;313(2):G150-G156. doi: 10.1152/ajpgi.00426.2016. Epub 2017 May 19.
6
N6-methyladenosine-modified long non-coding RNA promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression.N6-甲基腺苷修饰的长链非编码RNA通过上调SHOX2表达促进肝细胞癌的干性和索拉非尼耐药性。
World J Gastroenterol. 2024 Dec 28;30(48):5174-5190. doi: 10.3748/wjg.v30.i48.5174.
7
Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP.解析素 D1 通过抑制癌相关成纤维细胞来源的 COMP 的旁分泌作用,防止上皮间质转化,降低肝癌的干细胞特性。
J Exp Clin Cancer Res. 2019 Apr 18;38(1):170. doi: 10.1186/s13046-019-1163-6.
8
Matrix stiffening facilitates stemness of liver cancer stem cells by YAP activation and BMF inhibition.基质僵硬通过 YAP 激活和 BMF 抑制促进肝癌干细胞的干性。
Biomater Adv. 2024 Oct;163:213936. doi: 10.1016/j.bioadv.2024.213936. Epub 2024 Jul 1.
9
Clinical implication of long non-coding RNA NEAT1 expression in hepatocellular carcinoma patients.长链非编码RNA NEAT1表达在肝细胞癌患者中的临床意义
Int J Clin Exp Pathol. 2015 May 1;8(5):5395-402. eCollection 2015.
10
Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation.长链非编码 RNA NEAT1 通过脂肪甘油三酯酶调控异常脂肪分解促进肝癌增殖。
Mol Cancer. 2018 May 15;17(1):90. doi: 10.1186/s12943-018-0838-5.

引用本文的文献

1
FBXO42 promotes hepatocellular carcinoma progression via mediating p57Kip2 ubiquitination and degradation.FBXO42通过介导p57Kip2泛素化和降解促进肝细胞癌进展。
Eur J Med Res. 2025 Aug 21;30(1):784. doi: 10.1186/s40001-025-03050-z.

本文引用的文献

1
Biomolecular condensates: hubs of Hippo-YAP/TAZ signaling in cancer.生物分子凝聚物: Hippo-YAP/TAZ 信号在癌症中的枢纽。
Trends Cell Biol. 2024 Jul;34(7):566-577. doi: 10.1016/j.tcb.2024.04.009. Epub 2024 May 27.
2
Breaking the Tumor Chronic Inflammation Balance with a Programmable Release and Multi-Stimulation Engineering Scaffold for Potent Immunotherapy.利用可编程释放和多刺激工程支架打破肿瘤慢性炎症平衡,实现有效的免疫治疗。
Adv Sci (Weinh). 2024 Jul;11(28):e2401377. doi: 10.1002/advs.202401377. Epub 2024 May 17.
3
Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice.
免疫 PET 评估小鼠肿瘤内免疫治疗的局部和远处反应。
J Immunother Cancer. 2023 Nov;11(11). doi: 10.1136/jitc-2023-007433.
4
LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11-dependent repression of CDKN2A.长链非编码 RNA NEAT1 通过依赖 KIF11 的 CDKN2A 抑制抑制肝癌细胞衰老。
Clin Transl Med. 2023 Sep;13(9):e1418. doi: 10.1002/ctm2.1418.
5
LEF1 enhances β-catenin transactivation through IDR-dependent liquid-liquid phase separation.LEF1 通过 IDR 依赖性液-液相分离增强 β-连环蛋白的转录激活。
Life Sci Alliance. 2023 Sep 1;6(11). doi: 10.26508/lsa.202302118. Print 2023 Nov.
6
Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity.通过 GATA2-AS1 靶向 FUBP3 相分离抑制苹果酸-天冬氨酸穿梭和通过调节 SUZ12 活性抑制神经母细胞瘤进展。
Oncogene. 2023 Sep;42(36):2673-2687. doi: 10.1038/s41388-023-02798-0. Epub 2023 Aug 3.
7
Cancer-associated fibroblasts facilitate breast cancer progression through exosomal circTBPL1-mediated intercellular communication.肿瘤相关成纤维细胞通过外泌体 circTBPL1 介导的细胞间通讯促进乳腺癌的进展。
Cell Death Dis. 2023 Jul 26;14(7):471. doi: 10.1038/s41419-023-05986-8.
8
Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs.癌症相关成纤维细胞通过分泌外泌体来源的靶向ACSL4的微小RNA抑制胰腺癌细胞的铁死亡并诱导吉西他滨耐药。
Drug Resist Updat. 2023 May;68:100960. doi: 10.1016/j.drup.2023.100960. Epub 2023 Mar 28.
9
CD36 cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor.CD36 癌相关成纤维细胞通过分泌巨噬细胞迁移抑制因子为肝细胞癌提供免疫抑制微环境。
Cell Discov. 2023 Mar 6;9(1):25. doi: 10.1038/s41421-023-00529-z.
10
Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy.在肝癌微环境中鉴定决定免疫治疗疗效的肿瘤免疫屏障。
J Hepatol. 2023 Apr;78(4):770-782. doi: 10.1016/j.jhep.2023.01.011. Epub 2023 Jan 26.